159 related articles for article (PubMed ID: 35003894)
1. Mice transgenic for human
Lee GJ; Jun Y; Jeon YK; Lee D; Lee S; Kim J
Oncoimmunology; 2022; 11(1):2015170. PubMed ID: 35003894
[No Abstract] [Full Text] [Related]
2. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
[TBL] [Abstract][Full Text] [Related]
3. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
[TBL] [Abstract][Full Text] [Related]
4. Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):e271. PubMed ID: 27252517
[No Abstract] [Full Text] [Related]
5. Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.
Shin JH; Park HB; Oh YM; Lim DP; Lee JE; Seo HH; Lee SJ; Eom HS; Kim IH; Lee SH; Choi K
Blood; 2012 Jun; 119(24):5678-87. PubMed ID: 22538857
[TBL] [Abstract][Full Text] [Related]
6. Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Gong Q; Wang C; Rohr J; Feldman AL; Chan WC; McKeithan TW
Haematologica; 2016 Jun; 101(6):e269-70. PubMed ID: 27252516
[No Abstract] [Full Text] [Related]
7. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
8. Angioimmunoblastic T-cell lymphoma-like lymphadenopathy in mice transgenic for human
Lee GJ; Jun Y; Yoo HY; Jeon YK; Lee D; Lee S; Kim J
Oncoimmunology; 2020 May; 9(1):1746553. PubMed ID: 32923110
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD28/CTLA4-B7 costimulatory pathway in the development of lymphadenopathy and splenomegaly in MRL/lpr mice.
Takiguchi M; Murakami M; Nakagawa I; Rashid MM; Tosa N; Chikuma S; Hashimoto A; Uede T
J Vet Med Sci; 2000 Jan; 62(1):29-36. PubMed ID: 10676886
[TBL] [Abstract][Full Text] [Related]
10. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
Fallarino F; Fields PE; Gajewski TF
J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the T cell costimulatory receptors CD28 and CTLA4 in the European sea bass.
González-Fernández C; Esteban MA; Cuesta A
Fish Shellfish Immunol; 2021 Feb; 109():106-115. PubMed ID: 33348036
[TBL] [Abstract][Full Text] [Related]
12. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
14. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
15. CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy.
Park HB; Lee JE; Oh YM; Lee SJ; Eom HS; Choi K
Exp Mol Med; 2017 Jul; 49(7):e360. PubMed ID: 28751785
[TBL] [Abstract][Full Text] [Related]
16. Absence of CD28-CTLA4-PD-L1 Costimulatory Molecules Reduces Herpes Simplex Virus 1 Reactivation.
Matundan HH; Jaggi U; Yu J; Akbari O; Ghiasi H
mBio; 2021 Aug; 12(4):e0117621. PubMed ID: 34281386
[TBL] [Abstract][Full Text] [Related]
17. [The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL].
Ohshima K; Miyoshi H; Yamada K
Rinsho Ketsueki; 2018; 59(5):574-587. PubMed ID: 29877249
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.
Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L
Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.
Gmyrek GB; Pingel J; Choi J; Green JM
Cell Immunol; 2017 Sep; 319():28-34. PubMed ID: 28711152
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
